
LivaNova PLC
LIVN · NASDAQ · Healthcare / Medical Devices
Price History
Full chartMarket Stats
About
LivaNova PLC, a medical technology company, designs, develops, manufactures, markets, and sells products, therapies, and services. The company operates in two segments, Cardiopulmonary and Neuromodulation. The Cardiopulmonary segment provides cardiopulmonary products, including heart-lung machines, oxygenators, autotransfusion systems, perfusion tubing systems, cannula, and other related accessories, as well as services related products. The Neuromodulation segment offers VNS Therapy System, an implantable pulse generator and connective lead that stimulates the vagus nerve, surgical equipment to assist with the implant procedure, and equipment and instruction manuals; and devices that deliver neuromodulation therapy for treating drug-resistant epilepsy and depression. This segment also includes the development and clinical testing of aura6000 system for treating obstructive sleep apnea. It serves perfusionists, neurologists, neurosurgeons, hospitals, other healthcare professionals and medical institutions, and healthcare providers. The company sells its medical devices through direct sales representatives, agents, and independent distributors in the United States, the United Kingdom, Germany, France, Italy, the Netherlands, Spain, Belgium, Poland, Sweden, Switzerland, Austria, Norway, Portugal, Finland, Denmark, and internationally. LivaNova PLC was incorporated in 2015 and is headquartered in Gloucester, the United Kingdom.
Company Details
- SectorHealthcare
- IndustryMedical Devices
- CEOMr. Vladimir A. Makatsaria
- Employees3.30K
- Headquarters5220 Valiant Court, Gloucester, United Kingdom, GL3 4FE, USA
- Websitehttps://www.livanova.com
Leadership
- Mr. Vladimir A. MakatsariaCEO & Director · b. 1973
- Mr. Alex Shvartsburg C.M.A.Chief Financial Officer · b. 1970
- Ms. Natalia Sergeyevna KozminaChief Human Resources Officer · b. 1971
- Mr. Ahmet Tezel Ph.D.Chief Innovation Officer · b. 1975
- Ms. Lindsey LittleVP & Chief Accounting Officer
- Briana GotlinVice President of Investor Relations
- Ms. Anne M. LiddyChief Legal Officer · b. 1976
- Deanna WilkeVice President of Corporate Communications
- Mr. Philip KowalczykChief Strategy & Corporate Development Officer
- Mr. Paul R. BuckmanPresident of Advanced Circulatory Support & GM of Transcatheter Mitral Valve Replacement · b. 1956
Financials
Income Statement
Balance Sheet
Cash Flow
Earnings
Key Statistics & Ratios
Analyst Ratings
- Strong Buy6
- Buy3
- Hold2
Ownership Breakdown
- Institutions
- 115.74%
- Insiders
- 0.41%
- Retail / Other
- 0.00%
Top Institutional Holders
- BlackRock Inc7.57M13.73%
- PRIMECAP Management Company4.17M7.57%
- FMR Inc3.15M5.71%
- Hood River Capital Management LLC2.57M4.66%
- AQR Capital Management LLC2.36M4.28%
- Amvescap Plc.2.24M4.06%
- Artisan Partners Limited Partnership2.22M4.04%
- State Street Corp2.17M3.93%
- American Century Companies Inc2.01M3.66%
- Dimensional Fund Advisors, Inc.1.89M3.43%
- Geode Capital Management, LLC1.76M3.19%
- Wellington Management Company LLP1.74M3.16%
- Congress Asset Management Company, LLP1.50M2.73%
- Vanguard Portfolio Management, LLC1.41M2.57%
Top Fund Holders
- iShares Core S&P Mid-Cap ETF1.98M3.60%
- Vanguard Capital Opportunity Inv1.90M3.45%
- Invesco Small Cap Value A1.88M3.41%
- Avantis US Small Cap Value ETF1.60M2.91%
- iShares Russell 2000 ETF1.42M2.58%
- Hood River Small-Cap Growth Instl1.32M2.39%